You are here

TUNITAS THERAPEUTICS, INC.

Company Information
Address
409 Illinois Street
San Francisco, CA -
United States


http://www.tunitastherapeutics.com

Information

DUNS: 829828149

# of Employees: 8


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. A Human Fc Bifunctional Fusion Protein to Treat Severe Allergic Asthma

    Amount: $3,000,000.00

    DESCRIPTION provided by applicant The overall goal of this phase SBIR proposal is to position our novel biologic GE for human clinical trials in allergic disease though the completion of critical prec ...

    SBIRPhase II2013Department of Health and Human Services National Institutes of Health
  2. A therapeutic Fc gamma Fel d1 chimeric protein vaccine to treat cat allergy

    Amount: $3,000,000.00

    DESCRIPTION (provided by applicant): The overall goal of this phase 2 SBIR proposal is to develop and commercialize a novel biologic for allergen- specific immunotherapy as effective treatment for ca ...

    SBIRPhase II2012Department of Health and Human Services National Institutes of Health
  3. Therapeutic peanut allergen Fc gamma chimeric proteins to treat peanut allergy

    Amount: $1,699,968.00

    DESCRIPTION (provided by applicant): The overall goal of this Phase 2 STTR is to develop and commercialize a novel approach for allergen specific immunotherapy as a treatment for severe food allergy. ...

    STTRPhase II2012Department of Health and Human Services National Institutes of Health
  4. A Human Fc Bifunctional Fusion Protein to Treat Severe Allergic Asthma

    Amount: $443,494.00

    DESCRIPTION (provided by applicant): The overall goal of this proposal is to develop and commercialize a novel biologic therapy for the treatment of allergic disease and particularly allergic asthma. ...

    SBIRPhase I2011Department of Health and Human Services National Institutes of Health
  5. Cat allergen-human Fc-gamma1 chimeric proteins to treat cat allergy

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): The overall goal of this SBIR proposal is to develop and commercialize a new approach for allergen specific immunotherapy as treatment for cat allergy. This propo ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
  6. Allergen???Fc-gamma1 proteins to treat food allergy

    Amount: $172,386.00

    DESCRIPTION (provided by applicant): The goal of this proposal is to develop and commercialize a novel approach for allergen specific immunotherapy as treatment for severe food allergy. Food allergy ...

    STTRPhase I2010Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government